Clinical Trial Update: Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing insulin degludec to insulin glargine in type 2 diabetes patients, focusing on glycemic variability; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• insulin degludec (insulin degludec)

Snippet

Sponsor: University of Guadalajara | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2020-09-28